Yahoo Web Search

Search results

1. • 

     Not All COVID Patients Benefit From JAK Inhibitor

     MedPage Today· 6 days ago

     People randomized to the Janus kinase (JAK) inhibitor baricitinib (Olumiant) to treat COVID-19 pneumonia in a clinical trial only saw a survival benefit...

2. • 

     Pharma firm urged to share new 'game-changer' HIV drug

     AFP via Yahoo News· 4 days ago

     More than 300 politicians, health experts and celebrities called Thursday for US pharmaceutical...

3. • 

     Here’s what to expect as the Supreme Court enters the final stretch | CNN Politics

     CNN.com· 1 day ago

     The Supreme Court is turning toward the final, frenzied weeks of its term, readying potential...

4. • 

     Alcohol use disorder can be treated with an array of medications – but few people have heard of them

     PhillyVoice.com· 3 days ago

     The condition is characterized by a pattern of heavy alcohol consumption with loss of control over...

5. • Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM

     Digital Journal· 8 hours ago

     ...Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy...Vienna ball season back in full swing ‘Avatar 2’ success proves cinema in post-pandemic ‘resurgence’: Cameron North of Soledar, Ukrainians...Wedding Veil Inspiration’ Musk faces US fraud trial...

6. • NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq

     Digital Journal· 7 days ago

     Vienna ball season back in full swing ‘Avatar 2’ success proves cinema in post-pandemic ‘resurgence’: Cameron North of Soledar, Ukrainians yearn for peace Carlo Marks...new ...

7. • Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR...

     Morningstar· 5 days ago

     Efficacy and safety of AFM24 in combination with atezolizumab, a checkpoint inhibitor, is being evaluated in non-small cell lung cancer patients with EGFR wild-type and EGFR mutant advanced/ ...

8. • SafER has announced a Stage 3 clinical trial evaluating the SafER Negative Pressure System reducing...

     Digital Journal· 4 days ago

     "Our goal since the beginning of the pandemic has been to create a safer work environment for our friends and colleagues who are exposed to dangerous pathogens when performing ...

9. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 3 days ago

     Growing a robust, competitive, domestic biomanufacturing and life sciences sector ensures that Canada has access to critical vaccines, therapeutics and other life-saving medicines. The Government ...

10. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

      Roanoke-Chowan News-Herald· 3 days ago

      Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced general alignment with the U.S. Food and Drug ...